Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAPI
San Francisco, California, United Statesbio-api.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BioAPI is a synthetic biology company that focuses on creating a standardized interface for programming biological systems. The company aims to bridge the gap between computer science and biology by developing "Biological Application Programming Interfaces" (BioAPIs) that allow researchers to design and execute biological experiments with the same ease as writing software. Their platform is designed to streamline the engineering of organisms for various applications, including drug discovery, diagnostics, and industrial biotechnology. By providing a high-level abstraction for complex biological processes, BioAPI seeks to accelerate the pace of innovation in the life sciences sector.
- Modalities
- Synthetic biologyBiological API
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on BioAPI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioAPI.